Justin Meiklem

Vancouver, British Columbia and Rehovot, Israel – January 7, 2026– BioHarvest Sciences Inc.,  (Nasdaq: BHST) (FSE: 8MV0) (“BioHarvest” or “the Company”), a company pioneering its patented Botanical Synthesis technology process, today issued a letter to shareholder partners from Chief Executive Officer, Ilan Sobel. Dear Fellow Shareholders, 2025 marked an important milestone for BioHarvest Sciences: our first full […]

Vancouver, British Columbia and Rehovot, Israel – December 18, 2025 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”), (NASDAQ: BHST) (FSE: 8MV0), a biotechnology company pioneering its proprietary Botanical Synthesis™ platform, today announced that it has been awarded a $1.6 million grant from the Israeli Innovation Authority (IIA). The grant was approved under the IIA’s

First Hydration Formula Powered by VINIA’s Blood Flow Technology Enters the $13 Billion U.S. Electrolyte Market Vancouver, British Columbia and Rehovot, Israel, December 3, 2025 – BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV) (“BioHarvest” or “the Company”), a company pioneering its patented Botanical Synthesis technology platform, announces the U.S. launch of VINIA Blood Flow Hydration™,

Strong VINIA® Momentum and New CDMO Win Delivers  39% Year-Over-Year Growth Company Fortifies Balance Sheet with Recent $19.9 Million Instiutional Equity Raise Following $14.7 Million Strengthening of Balance Sheet via  Accelerated Warrant Exercises and Debt-to-Equity Conversions in September Rehovot, Israel – November 13, 2025 – BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) (“BioHarvest” or the